Glycogen synthase kinase 3: a key regulator of cellular fate
- PMID: 17530463
- PMCID: PMC11136264
- DOI: 10.1007/s00018-007-7045-7
Glycogen synthase kinase 3: a key regulator of cellular fate
Abstract
The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified as a key regulator of insulin-dependent glycogen synthesis. GSK-3 was subsequently shown to function in a wide range of cellular processes including differentiation, growth, motility and apoptosis. Aberrant regulation of GSK-3 has been implicated in a range of human pathologies including Alzheimer's disease, non-insulin-dependent diabetes mellitus (NIDDM) and cancer. As a consequence, the regulation of GSK-3 and the therapeutic potential of GSK-3 inhibitors have become key areas of investigation. This review will focus on the mechanisms of GSK-3 regulation, with emphasis on modulation by upstream signals, control of substrate specificity and GSK-3 localisation. The details of these mechanisms will be discussed in the context of specific signalling pathways.
Similar articles
-
Glycogen synthase kinase-3--an overview of an over-achieving protein kinase.Curr Drug Targets. 2006 Nov;7(11):1377-88. doi: 10.2174/1389450110607011377. Curr Drug Targets. 2006. PMID: 17100578 Review.
-
GSK-3 as potential target for therapeutic intervention in cancer.Oncotarget. 2014 May 30;5(10):2881-911. doi: 10.18632/oncotarget.2037. Oncotarget. 2014. PMID: 24931005 Free PMC article. Review.
-
Glycogen Synthase Kinase 3: A Kinase for All Pathways?Curr Top Dev Biol. 2017;123:277-302. doi: 10.1016/bs.ctdb.2016.11.011. Epub 2016 Dec 28. Curr Top Dev Biol. 2017. PMID: 28236969 Review.
-
Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6.Elife. 2014 Mar 18;3:e01998. doi: 10.7554/eLife.01998. Elife. 2014. PMID: 24642411 Free PMC article.
-
The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.Biomed Pharmacother. 2020 Aug;128:110249. doi: 10.1016/j.biopha.2020.110249. Epub 2020 May 26. Biomed Pharmacother. 2020. PMID: 32470749
Cited by
-
Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine.PLoS One. 2016 Jun 10;11(6):e0156877. doi: 10.1371/journal.pone.0156877. eCollection 2016. PLoS One. 2016. PMID: 27284979 Free PMC article.
-
Regulation of autophagic cell death by glycogen synthase kinase-3β in adult hippocampal neural stem cells following insulin withdrawal.Mol Brain. 2015 May 19;8:30. doi: 10.1186/s13041-015-0119-9. Mol Brain. 2015. PMID: 25986948 Free PMC article.
-
Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.BMC Cancer. 2010 Feb 23;10:58. doi: 10.1186/1471-2407-10-58. BMC Cancer. 2010. PMID: 20178594 Free PMC article.
-
Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.PLoS Genet. 2010 Sep 2;6(9):e1001087. doi: 10.1371/journal.pgen.1001087. PLoS Genet. 2010. PMID: 20824130 Free PMC article.
-
Elaborate the Mechanism of Ancient Classic Prescriptions (Erzhi Formula) in Reversing GIOP by Network Pharmacology Coupled with Zebrafish Verification.Evid Based Complement Alternat Med. 2022 Jan 10;2022:7019792. doi: 10.1155/2022/7019792. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35047047 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials